A detailed history of Front Row Advisors LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 9,400 shares of MEDP stock, worth $2.9 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
9,400
Previous 9,286 1.23%
Holding current value
$2.9 Million
Previous $3.82 Million 18.04%
% of portfolio
1.16%
Previous 1.36%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $36,546 - $52,131
114 Added 1.23%
9,400 $3.13 Million
Q2 2024

Aug 15, 2024

SELL
$372.0 - $424.34 $613,800 - $700,161
-1,650 Reduced 15.09%
9,286 $3.82 Million
Q1 2024

May 14, 2024

SELL
$284.87 - $413.31 $1,424 - $2,066
-5 Reduced 0.05%
10,936 $4.42 Million
Q4 2023

Feb 15, 2024

BUY
$227.52 - $312.68 $4,550 - $6,253
20 Added 0.18%
10,941 $3.35 Million
Q3 2023

Nov 15, 2023

BUY
$233.98 - $281.67 $12,868 - $15,491
55 Added 0.51%
10,921 $2.64 Million
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $56,927 - $73,011
-304 Reduced 2.72%
10,866 $2.61 Million
Q1 2023

May 22, 2023

BUY
$174.31 - $239.52 $1.58 Million - $2.17 Million
9,069 Added 431.65%
11,170 $2.1 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $1.58 Million - $2.17 Million
-9,054 Reduced 81.17%
2,101 $1.12 Million
Q4 2022

Feb 15, 2023

SELL
$153.06 - $226.57 $104,693 - $154,973
-684 Reduced 5.78%
11,155 $2.37 Million
Q3 2022

Nov 15, 2022

BUY
$145.13 - $182.49 $8,707 - $10,949
60 Added 0.51%
11,839 $1.86 Million
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $1,952 - $2,520
-15 Reduced 0.13%
11,779 $1.76 Million
Q1 2022

May 11, 2022

BUY
$138.87 - $214.31 $136,786 - $211,095
985 Added 9.11%
11,794 $1.93 Million
Q4 2021

Mar 09, 2022

BUY
$182.74 - $227.9 $74,740 - $93,211
409 Added 3.93%
10,809 $2.35 Million
Q3 2021

Nov 03, 2021

BUY
$170.18 - $198.21 $25,527 - $29,731
150 Added 1.46%
10,400 $1.97 Million
Q2 2021

Aug 23, 2021

BUY
$158.62 - $194.3 $112,620 - $137,953
710 Added 7.44%
10,250 $1.81 Million
Q1 2021

Apr 28, 2021

BUY
$132.02 - $168.26 $73,271 - $93,384
555 Added 6.18%
9,540 $1.57 Million
Q4 2020

Feb 25, 2021

SELL
$109.38 - $149.19 $6,562 - $8,951
-60 Reduced 0.66%
8,985 $1.25 Million
Q3 2020

Nov 30, 2020

BUY
$92.95 - $130.61 $6,041 - $8,489
65 Added 0.72%
9,045 $1.12 Million
Q2 2020

Aug 17, 2020

SELL
$68.08 - $95.68 $3,744 - $5,262
-55 Reduced 0.61%
8,980 $835,000
Q1 2020

May 08, 2020

BUY
$61.71 - $101.95 $557,549 - $921,118
9,035 New
9,035 $722,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.61B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.